MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice

Brain Research

Volumn 971, Issue 1, 2003, Pages 95-106

  Grabill, Colette ^a,b   Silva, Afonso C ^c   Smith, Sophia S ^a   Koretsky, Alan P ^c   Rouault, Tracey A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Brain; Ferritin; Iron regulatory protein; Magnetic resonance imaging; Neurodegenerative disease; Vacuolization

Indexed keywords

FERRITIN; IRON; IRON REGULATORY FACTOR; IRON REGULATORY PROTEIN 2; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN WATER; CELL VACUOLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEVICE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IRON OVERLOAD; KNOCKOUT MOUSE; MAGNET; MALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PRIORITY JOURNAL; PROTEIN DEPLETION; STAINING; SUBSTANTIA NIGRA; SUPERIOR COLLICULUS;

EID: 0347367315     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02366-7     Document Type: Article

References (38)

1. Aisen P., Enns C., Wessling-Resnick M. Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell. Biol. 33:2002;940-959.
2. Anderson G., Powell L. Of metals, mice, and men: what animal models can teach us about body iron loading. J. Clin. Invest. 105:2000;1185-1186.
3. Bartzokis G., Tishler T.A. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntington's disease. Cell. Mol. Biol. 46:2000;821-833.
4. Benner T., Heiland S., Erb G., Forsting M., Sartor K. Accuracy of gamma variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magn. Reson. Imaging. 15:1997;307-317.
5. Berg D., Gerlach M., Youdin M.B.H., Double K.L., Zecca L., Riederer P., Becker G. Brain iron pathways and their relevance to Parkinson's disease. J. Neurochem. 79:2002;225-236.
6. Campbell C., Smith M., Sayre L., Bondy S., Perry G. Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res. Bull. 55:2001;125-132.
7. Chen J., Hardy P., Kucharczyk W., Clauberg M., Joshi J., Vourlas A., Dhar M., Henkelman R.M. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. Am. J. Neuroradiol. 14:1993;275-281.
8. Curtis A.R., Fey C., Morris C., Bindoff L., Ince P., Chinnery P., Coulthad A., Jackson M., Jackson A., McHale D., Hay D., Barker W., Markham A., Bates D., Curtis A., Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 28:2001;350-354.
9. Dehmeshki J., Barker G.J., Tofts P.S. Classification of disease subgroup and correlation with disease severity using magnetic resonance imaging whole-brain histograms: application to magnetization transfer ratios and multiple sclerosis. IEEE Trans. Med. Imaging. 21:2002;320-331.
10. Dickson D., Lin W., Liu W., Yen S. Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol. 9:1999;721-732.
11. Drayer B., Burger P., Darwin R., Riederer S., Herfkens R., Johnson G.A. MRI of brain iron. Am. J. Roentgenol. 147:1986;103-110.
12. Gerlach M., Ben-Shachar D., Riederer P., H Youdim M.B. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
13. Hayat M.A. Principles and Techniques of Electron Microscopy. 1970;Van Nostrand Reinhold, New York.
14. Hayflick S., Penzien J., Michl W., Sharif U., Rosman N.P., Wheeler P. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome. Pediatr. Neurol. 25:2001;166-169.
15. Hilditch-Maguire P., Trettel F., Passani L., Auerbach A., Persichetti F., MacDonald M. Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum. Mol. Genet. 9:2000;2789-2797.
16. Hill J.M. The distribution of iron in the brain. Youdim M.B.H. Brain Iron: Neurochemical and Behavioral Aspects. 1988;1-24 Taylor and Francis, London.
17. Koeppen A.H. The history of iron in the brain. J. Neurol. Sci. 134:(Suppl.):1995;1-9.
18. Lang A., Curran T., Provias J., Bergeron C. Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging. Can. J. Neurol. Sci. 21:1994;311-318.
19. LaVaute T., Smith S., Cooperman S., Iwai K., Land W., Meyron-Holtz E., Drake S., Miller G., Abu-Asab M., Tsokos M., Switzer R. III, Grinberg A., Love P., Tresser N., Rouault T. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27:2001;209-214.
20. Levine S. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 760:1997;298-303.
21. Mao-Draayer Y., Braff S.P., Nagle K.J., Pendlebury W., Penar P.L., Shapiro R.E. Emerging patterns of diffusion-weighted MR imaging in Creutzfeldt-Jakob disease: case report and review of the literature. Am. J. Neuroradiol. 23:2002;550-556.
22. Morris C.M., Candy J.M., Oakley A.E., Bloxham C.A., Edwardson J.A. Histochemical distribution of non-haem iron in the human brain. Acta Anat. 144:1992;235-257.
23. Nielsen J.E., Jensen L.N., Krabbe K. Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome. J. Neurol. Neurosurg. Psychiatry. 59:1995;318-321.
24. Parsey R.V., Krishnan K.R. A new MRI ratio method for in vivo estimation of signal hypointensity in aging and Alzheimer's disease. Prog. Neuro-Psycholopharmacol. Biol. Psychiat. 21:1997;1257-1267.
25. Parsey R.V., Krishnan K.R. Quantitative analysis of T2 signal intensities in Alzheimer's disease. Psychiatry Res. 82:1998;181-185.
26. Puccio H., Simon D., Cossee M., Criqui-Filipe O., Tiziano F., Melki J., Hindelang C., Matyas R., Rustin P., Koenig M. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet. 27:2001;181-186.
27. Rausch M., Scheffler K., Rudin M., Radu E.W. Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. Magn. Reson. Imaging. 18:2000;1235-1243.
28. Rouault T., Klausner R.D. Regulation of iron metabolism in eukaryotes. Curr. Top. Cell. Regul. 35:1997;1-19.
29. Sax D.S., Buonanno F.S. Putaminal changes in spin-echo magnetic resonance imaging signal in bradykinetic/rigid forms of Huntington's disease. Neurology. 36:1986;311.
30. Su J., Kesslak J.P., Head E., Cotman C. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain. Acta Neuropathol. 104:2002;1-6.
31. Sy M.S., Gambetti P., Wong B.S. Human prion diseases. Med. Clin. North Am. 86:2002;551-571.
32. Thompson K., Shoham S., Connor J.R. Iron and neurodegenerative disorders. Brain Res. Bull. 55:2002;155-164.
33. Tribl G.G., Strasser G., Zeitlhofer J., Asenbaum S., Jarius C., Wessely P., Prayer D. Sequential MRI in a case of Creutzfeldt-Jakob disease. Neuroradiology. 44:2002;223-226.
34. Uemura A., O'uchi T., Sakamoto T., Yashiro N. High signal of the striatum in sporadic Creutzfeldt-Jakob disease: sequential change on T2-weighted MRI. Neuroradiology. 44:2002;314-318.
35. Ulfig N. Neuronal vacuolation in the basal nucleus of meynert caused by fetal hydrocephalus. Pediatr. Neurosurg. 36:2002;320-323.
36. Vymazal J., Righini A., Brooks R., Canesi M., Mariani C., Leonardi M., Pezzoli G. T1 and T2 in the brain of healthy subjects, Patients with Parkinson disease, and patients with Multiple System atrophy: relation to iron content. Radiology. 211:1999;489-495.
37. Zhou B., Westaway S., Levinson B., Johnson M., Gitschier J., Hayflick S. A novel pantothenate kinase (PANK2) gene is defective in Hallervorden-Spatz syndrome. Nat. Genet. 28:2001;345-349.
38. Zywicke H., van Gelderen P., Connor J., Burdo J., Garrick M., Dolan K., Frank J., Bulte J. Microscopic R2* mapping of reduced brain iron in the Belgrade rat. Ann. Neurol. 52:2002;102-105.